Truist Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
38,949
-5,284
| -12% | -$2.77M | 0.03% | 397 |
|
|
2025
Q1 | $28.1M | Sell |
44,233
-15,070
| -25% | -$9.56M | 0.04% | 311 |
|
|
2024
Q4 | $42.2M | Buy |
59,303
+22,192
| +60% | +$15.8M | 0.07% | 258 |
|
|
2024
Q3 | $39M | Sell |
37,111
-3,110
| -8% | -$3.27M | 0.06% | 273 |
|
|
2024
Q2 | $42.3M | Sell |
40,221
-1,630
| -4% | -$1.71M | 0.06% | 258 |
|
|
2024
Q1 | $40.3M | Sell |
41,851
-2,530
| -6% | -$2.44M | 0.06% | 268 |
|
|
2023
Q4 | $39M | Sell |
44,381
-8,062
| -15% | -$7.08M | 0.06% | 270 |
|
|
2023
Q3 | $43.2M | Sell |
52,443
-28,515
| -35% | -$23.5M | 0.07% | 242 |
|
|
2023
Q2 | $58.2M | Sell |
80,958
-13,849
| -15% | -$9.95M | 0.1% | 195 |
|
|
2023
Q1 | $77.9M | Sell |
94,807
-16,129
| -15% | -$13.3M | 0.13% | 156 |
|
|
2022
Q4 | $80M | Sell |
110,936
-6,189
| -5% | -$4.47M | 0.14% | 150 |
|
|
2022
Q3 | $80.7M | Sell |
117,125
-8,560
| -7% | -$5.9M | 0.15% | 134 |
|
|
2022
Q2 | $74.3M | Sell |
125,685
-10,239
| -8% | -$6.05M | 0.14% | 153 |
|
|
2022
Q1 | $94.9M | Sell |
135,924
-6,610
| -5% | -$4.62M | 0.15% | 142 |
|
|
2021
Q4 | $90M | Sell |
142,534
-187
| -0.1% | -$118K | 0.14% | 160 |
|
|
2021
Q3 | $86.4M | Sell |
142,721
-7,077
| -5% | -$4.28M | 0.14% | 157 |
|
|
2021
Q2 | $83.7M | Buy |
149,798
+19,063
| +15% | +$10.6M | 0.14% | 158 |
|
|
2021
Q1 | $61.9M | Buy |
130,735
+56,371
| +76% | +$26.7M | 0.11% | 198 |
|
|
2020
Q4 | $35.9M | Buy |
74,364
+7,761
| +12% | +$3.75M | 0.07% | 257 |
|
|
2020
Q3 | $37.3M | Sell |
66,603
-5,810
| -8% | -$3.25M | 0.08% | 233 |
|
|
2020
Q2 | $45.2M | Buy |
72,413
+6,681
| +10% | +$4.17M | 0.1% | 204 |
|
|
2020
Q1 | $32.1M | Buy |
65,732
+26,797
| +69% | +$13.1M | 0.08% | 238 |
|
|
2019
Q4 | $14.6M | Buy |
38,935
+17,419
| +81% | +$6.54M | 0.03% | 485 |
|
|
2019
Q3 | $5.97M | Buy |
21,516
+1,554
| +8% | +$431K | 0.1% | 197 |
|
|
2019
Q2 | $6.25M | Buy |
19,962
+120
| +0.6% | +$37.6K | 0.11% | 192 |
|
|
2019
Q1 | $8.15M | Buy |
19,842
+1,234
| +7% | +$507K | 0.15% | 152 |
|
|
2018
Q4 | $6.95M | Buy |
18,608
+1,953
| +12% | +$730K | 0.14% | 155 |
|
|
2018
Q3 | $6.73M | Buy |
16,655
+1,665
| +11% | +$673K | 0.12% | 191 |
|
|
2018
Q2 | $5.17M | Buy |
14,990
+2,668
| +22% | +$921K | 0.1% | 227 |
|
|
2018
Q1 | $4.24M | Buy |
12,322
+1,507
| +14% | +$519K | 0.08% | 261 |
|
|
2017
Q4 | $4.07M | Buy |
10,815
+686
| +7% | +$258K | 0.08% | 269 |
|
|
2017
Q3 | $4.53M | Buy |
10,129
+1,034
| +11% | +$462K | 0.09% | 258 |
|
|
2017
Q2 | $4.47M | Buy |
9,095
+1,213
| +15% | +$596K | 0.09% | 264 |
|
|
2017
Q1 | $3.05M | Buy |
7,882
+2,681
| +52% | +$1.04M | 0.06% | 309 |
|
|
2016
Q4 | $1.91M | Buy |
5,201
+2,579
| +98% | +$947K | 0.04% | 373 |
|
|
2016
Q3 | $1.05M | Buy |
+2,622
| New | +$1.05M | 0.02% | 466 |
|